M
MDxHealth SA
NASDAQ:MDXH
MDxHealth SA
NASDAQ:MDXH
Price:
3.16
USD
-3.07%
Market Closed
Market Cap:
$156.4m
Relative Value
The Relative Value of one MDXH stock under the Base Case scenario is 3.68 USD. Compared to the current market price of 3.16 USD, MDxHealth SA is Undervalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MDXH
Relative Value
Base Case
3.68
USD
Undervaluation 14%
M
Multiples Across Competitors
MDXH Competitors Multiples
MDxHealth SA Competitors
MDxHealth SA Competitors
All Countries
| Market Cap | P/S | P/E | P/B | ||||
|---|---|---|---|---|---|---|---|
| BE |
M
|
MDxHealth SA
NASDAQ:MDXH
|
156.4m USD | 1.4 | -4.7 | -12.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -164 720.7 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | -110.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 21.6 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 7.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 6.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -5 465.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 2.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 2.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | 18.2 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 52.4 |
P/S Multiple
P/E Multiple
P/B Multiple
